225 related articles for article (PubMed ID: 26639824)
1. Adelmidrol increases the endogenous concentrations of palmitoylethanolamide in canine keratinocytes and down-regulates an inflammatory reaction in an in vitro model of contact allergic dermatitis.
Petrosino S; Puigdemont A; Della Valle MF; Fusco M; Verde R; Allarà M; Aveta T; Orlando P; Di Marzo V
Vet J; 2016 Jan; 207():85-91. PubMed ID: 26639824
[TBL] [Abstract][Full Text] [Related]
2. Harnessing the anti-inflammatory potential of palmitoylethanolamide.
Alhouayek M; Muccioli GG
Drug Discov Today; 2014 Oct; 19(10):1632-9. PubMed ID: 24952959
[TBL] [Abstract][Full Text] [Related]
3. Protective role of palmitoylethanolamide in contact allergic dermatitis.
Petrosino S; Cristino L; Karsak M; Gaffal E; Ueda N; Tüting T; Bisogno T; De Filippis D; D'Amico A; Saturnino C; Orlando P; Zimmer A; Iuvone T; Di Marzo V
Allergy; 2010 Jun; 65(6):698-711. PubMed ID: 19909294
[TBL] [Abstract][Full Text] [Related]
4. Adelmidrol, a palmitoylethanolamide analogue, reduces chronic inflammation in a carrageenin-granuloma model in rats.
De Filippis D; D'Amico A; Cinelli MP; Esposito G; Di Marzo V; Iuvone T
J Cell Mol Med; 2009 Jun; 13(6):1086-95. PubMed ID: 18429935
[TBL] [Abstract][Full Text] [Related]
5. N-acylethanolamine-hydrolyzing acid amidase and fatty acid amide hydrolase inhibition differentially affect N-acylethanolamine levels and macrophage activation.
Alhouayek M; Bottemanne P; Makriyannis A; Muccioli GG
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 May; 1862(5):474-484. PubMed ID: 28065729
[TBL] [Abstract][Full Text] [Related]
6. A Glucuronic Acid-Palmitoylethanolamide Conjugate (GLUPEA) Is an Innovative Drug Delivery System and a Potential Bioregulator.
Manzo E; Schiano Moriello A; Tinto F; Verde R; Allarà M; De Petrocellis L; Pagano E; Izzo AA; Di Marzo V; Petrosino S
Cells; 2021 Feb; 10(2):. PubMed ID: 33672574
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of topical adelmidrol on antigen-induced skin wheal and mast cell behavior in a canine model of allergic dermatitis.
Cerrato S; Brazis P; Della Valle MF; Miolo A; Puigdemont A
BMC Vet Res; 2012 Nov; 8():230. PubMed ID: 23181761
[TBL] [Abstract][Full Text] [Related]
8. N-Acylethanolamine-hydrolyzing acid amidase inhibition increases colon N-palmitoylethanolamine levels and counteracts murine colitis.
Alhouayek M; Bottemanne P; Subramanian KV; Lambert DM; Makriyannis A; Cani PD; Muccioli GG
FASEB J; 2015 Feb; 29(2):650-61. PubMed ID: 25384424
[TBL] [Abstract][Full Text] [Related]
9. The anti-inflammatory mediator palmitoylethanolamide enhances the levels of 2-arachidonoyl-glycerol and potentiates its actions at TRPV1 cation channels.
Petrosino S; Schiano Moriello A; Cerrato S; Fusco M; Puigdemont A; De Petrocellis L; Di Marzo V
Br J Pharmacol; 2016 Apr; 173(7):1154-62. PubMed ID: 25598150
[TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory Properties of Cannabidiol, a Nonpsychotropic Cannabinoid, in Experimental Allergic Contact Dermatitis.
Petrosino S; Verde R; Vaia M; Allarà M; Iuvone T; Di Marzo V
J Pharmacol Exp Ther; 2018 Jun; 365(3):652-663. PubMed ID: 29632236
[TBL] [Abstract][Full Text] [Related]
11. Effects of palmitoylethanolamide on immunologically induced histamine, PGD2 and TNFalpha release from canine skin mast cells.
Cerrato S; Brazis P; della Valle MF; Miolo A; Puigdemont A
Vet Immunol Immunopathol; 2010 Jan; 133(1):9-15. PubMed ID: 19625089
[TBL] [Abstract][Full Text] [Related]
12. Adelmidrol, a Palmitoylethanolamide Analogue, as a New Pharmacological Treatment for the Management of Inflammatory Bowel Disease.
Cordaro M; Impellizzeri D; Gugliandolo E; Siracusa R; Crupi R; Esposito E; Cuzzocrea S
Mol Pharmacol; 2016 Nov; 90(5):549-561. PubMed ID: 27625036
[TBL] [Abstract][Full Text] [Related]
13. Palmitoylethanolamide counteracts substance P-induced mast cell activation in vitro by stimulating diacylglycerol lipase activity.
Petrosino S; Schiano Moriello A; Verde R; Allarà M; Imperatore R; Ligresti A; Mahmoud AM; Peritore AF; Iannotti FA; Di Marzo V
J Neuroinflammation; 2019 Dec; 16(1):274. PubMed ID: 31878942
[TBL] [Abstract][Full Text] [Related]
14. Anti-Inflammatory Effects of Fucoxanthinol in LPS-Induced RAW264.7 Cells through the NAAA-PEA Pathway.
Jin W; Yang L; Yi Z; Fang H; Chen W; Hong Z; Zhang Y; Zhang G; Li L
Mar Drugs; 2020 Apr; 18(4):. PubMed ID: 32326173
[TBL] [Abstract][Full Text] [Related]
15. Diacerein is a potent and selective inhibitor of palmitoylethanolamide inactivation with analgesic activity in a rat model of acute inflammatory pain.
Petrosino S; Ahmad A; Marcolongo G; Esposito E; Allarà M; Verde R; Cuzzocrea S; Di Marzo V
Pharmacol Res; 2015 Jan; 91():9-14. PubMed ID: 25447594
[TBL] [Abstract][Full Text] [Related]
16. Palmitoylethanolamide reduces inflammation and itch in a mouse model of contact allergic dermatitis.
Vaia M; Petrosino S; De Filippis D; Negro L; Guarino A; Carnuccio R; Di Marzo V; Iuvone T
Eur J Pharmacol; 2016 Nov; 791():669-674. PubMed ID: 27720681
[TBL] [Abstract][Full Text] [Related]
17. Expression and secretion of N-acylethanolamine-hydrolysing acid amidase in human prostate cancer cells.
Wang J; Zhao LY; Uyama T; Tsuboi K; Wu XX; Kakehi Y; Ueda N
J Biochem; 2008 Nov; 144(5):685-90. PubMed ID: 18806270
[TBL] [Abstract][Full Text] [Related]
18. Effect on cancer cell proliferation of palmitoylethanolamide, a fatty acid amide interacting with both the cannabinoid and vanilloid signalling systems.
De Petrocellis L; Bisogno T; Ligresti A; Bifulco M; Melck D; Di Marzo V
Fundam Clin Pharmacol; 2002 Aug; 16(4):297-302. PubMed ID: 12570018
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological properties of rat brain fatty acid amidohydrolase in different subcellular fractions using palmitoylethanolamide as substrate.
Tiger G; Stenström A; Fowler CJ
Biochem Pharmacol; 2000 Mar; 59(6):647-53. PubMed ID: 10677581
[TBL] [Abstract][Full Text] [Related]
20. Synergic Therapeutic Potential of PEA-Um Treatment and NAAA Enzyme Silencing In the Management of Neuroinflammation.
Casili G; Lanza M; Campolo M; Siracusa R; Paterniti I; Ardizzone A; Scuderi SA; Cuzzocrea S; Esposito E
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
